YAZ PLUS

국가: 이스라엘

언어: 영어

출처: Ministry of Health

지금 구매하세요

환자 정보 전단 환자 정보 전단 (PIL)
28-02-2023
제품 특성 요약 제품 특성 요약 (SPC)
16-08-2022
공공 평가 보고서 공공 평가 보고서 (PAR)
20-04-2020

유효 성분:

DROSPIRENONE; ETHINYLESTRADIOL AS BETADEX CLATHRATE; LEVOMEFOLATE CALCIUM; LEVOMEFOLATE CALCIUM

제공처:

BAYER ISRAEL LTD

ATC 코드:

G03CA53

약제 형태:

FILM COATED TABLETS

구성:

LEVOMEFOLATE CALCIUM 0.451 MG; ETHINYLESTRADIOL AS BETADEX CLATHRATE 0.02 MG; DROSPIRENONE 3 MG; LEVOMEFOLATE CALCIUM 0.451 MG

관리 경로:

PER OS

처방전 유형:

Required

Manufactured by:

BAYER WEIMAR GMBH UND CO.KG, GERMANY

치료 영역:

ESTRADIOL, COMBINATIONS

치료 징후:

- Oral contraception. - Treatment of symptoms of premenstrual dysphoric disorder (PMDD ) in women who choose to use an oral contraceptive as their method of birth control.- Treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. - In women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.

승인 날짜:

2019-09-30

환자 정보 전단

                                PACKAGING TECHNOLOGY BERLIN SGQCL
Bayer AG
client: JS86
material-no.: 89354609
PZ: 2701A-4
code-no.:
name: LF-BRO YAZ PLUS TAFI 3X28
country: IL/MULI/BAG
colors: BLACK /
version: 03.01.2023/02
Restricted Document
dimension: 95 X 66 MM
page 54
colors: BLACK /
54
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986
The medicine is dispensed with a doctor’s prescription only
YAZ PLUS
FILM-COATED TABLETS
Each pink tablet contains:
Drospirenone 3 mg
Ethinylestradiol (as betadex clathrate) 0.02 mg
Levomefolate calcium 0.451 mg
Each light-orange tablet contains:
Levomefolate calcium 0.451 mg
Inactive ingredients and allergens: See section 6 “Additional
information” and
section 2 “Important information regarding some of the ingredients
of the
medicine”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THIS MEDICINE. This
leaflet
contains concise information about this medicine. If you have any
further
questions, consult your doctor or pharmacist.
PACKAGING TECHNOLOGY BERLIN SGQCL
Bayer AG
client: JS86
material-no.: 89354609
PZ: 2701A-4
code-no.:
name: LF-BRO YAZ PLUS TAFI 3X28
country: IL/MULI/BAG
colors: BLACK /
version: 03.01.2023/02
Restricted Document
dimension: 95 X 66 MM
page 55
colors: BLACK /
55
This medicine has been prescribed for you to prevent pregnancy. Do not
pass it
on to others. It may harm them even if it seems to you that the
purpose of use
is similar.
ESSENTIAL INFORMATION ABOUT THE MEDICINE
•
Do not use Yaz Plus if you smoke and are over 35 years of age. Taking
birth
control pills while smoking increases your risk of developing serious
cardiac
side effects (cardiovascular problems), including death due to heart
attack,
blood clots or stroke. This risk increases with age and the number of
cigarettes
you smoke.
•
Birth control pills lower the chance of becoming pregnant if taken
according to
the instructions. They do not protect against contraction of AIDS or
any other
sexually transmitted disease.
1)
WHAT IS THIS MEDICINE INTENDED FOR?
Yaz Plus is i
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                1
YAZ PLUS
Film coated tablets
Drospirenone
3 mg
Ethinylestradiol as betadex calthrate
0.02 mg
Levomefolate calcium
0.451 mg
WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS
CIGARETTE SMOKING INCREASES THE RISK OF SERIOUS CARDIOVASCULAR EVENTS
FROM COMBINATION
ORAL CONTRACEPTIVES (COC) USE. THIS RISK INCREASES WITH AGE,
PARTICULARLY IN WOMEN OVER
35 YEARS OF AGE, AND WITH THE NUMBER OF CIGARETTES SMOKED. FOR THIS
REASON, COCS SHOULD
NOT BE USED BY WOMEN WHO ARE OVER 35 YEARS OF AGE AND SMOKE _[SEE
CONTRAINDICATIONS (4)]_.
1 INDICATIONS AND USAGE
- Oral contraception.
- Treatment of symptoms of premenstrual dysphoric disorder (PMDD ) in
women who choose to use an oral contraceptive
as their method of birth control.
- Treatment of moderate acne vulgaris in women at least 14 years of
age, who have no known contraindications to oral
contraceptive therapy and have achieved menarche.
- In women who choose to use an oral contraceptive as their method of
contraception, to raise folate levels for the purpose
of reducing the risk of a neural tube defect in a pregnancy conceived
while taking the product or shortly after
discontinuing the product.
2 DOSAGE AND ADMINISTRATION
2.1 HOW TO TAKE YAZ PLUS
Take one tablet by mouth at the same time every day. The failure rate
may increase when pills are missed or taken
incorrectly.
To achieve maximum contraceptive and PMDD effectiveness, Yaz Plus must
be taken as directed, in the order directed on
the blister pack. Single missed pills should be taken as soon as
remembered.
2.2 HOW TO START YAZ PLUS
Instruct the patient to begin taking Yaz Plus either on the first day
of her menstrual period (Day 1 Start) or on the first
Sunday after the onset of her menstrual period (Sunday Start).
_Day 1 Start _
During the first cycle of Yaz Plus use, instruct the patient to take
one pink Yaz Plus daily, beginning on Day 1 of her
menstrual cycle. (The first day of menstruation is Day 1.) She should
take one pink Yaz Plus daily for 24 consecutive
days, followed by one light orange tablet
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 아랍어 28-02-2023
환자 정보 전단 환자 정보 전단 히브리어 28-02-2023

문서 기록보기